BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Zhang L, Li Z, Liu Y, et al. (2018) Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma. Bmc Cancer. 18: 1107 |
Lu S, Concha-Benavente F, Shayan G, et al. (2018) STING activation enhances cetuximab-mediated NK cell activation and DC maturation and correlates with HPVstatus in head and neck cancer. Oral Oncology. 78: 186-193 |
Stabile LP, Egloff AM, Gibson MK, et al. (2017) IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer. Oral Oncology. 69: 38-45 |
Bauman JE, Duvvuri U, Gooding WE, et al. (2017) Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancer. Jci Insight. 2: e90449 |
Hedberg ML, Peyser N, Gooding W, et al. (2017) Abstract 1779: Chronic NSAID use increases survival inPIK3CA-altered head and neck squamous cell carcinoma Cancer Research. 77: 1779-1779 |
Bauman JE, Zang Y, Sen M, et al. (2016) Prevention of Carcinogen-Induced Oral Cancer by Sulforaphane. Cancer Prevention Research (Philadelphia, Pa.) |
Peyser ND, Wang L, Zeng Y, et al. (2016) STAT3 as a chemoprevention target in carcinogen-induced head and neck squamous cell carcinoma. Cancer Prevention Research (Philadelphia, Pa.) |
Hedberg ML, Goh G, Chiosea SI, et al. (2016) Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma. The Journal of Clinical Investigation. 126: 1606 |
Ledgerwood LG, Kumar D, Eterovic AK, et al. (2016) The degree of intratumor mutational heterogeneity varies by primary tumor sub-site. Oncotarget |
Peyser ND, Wang L, Acquafondata M, et al. (2016) Abstract 5243: STAT3 inhibition as chemoprevention in a chemically induced mouse model of HNSCC Cancer Research. 76: 5243-5243 |